Interesting- The Surgeon is correct in that many big claims are made by many. The Proof is far more interesting given the US hospital roll out I and the still large single to double digit post surgical complication by avoidable wound infections where Best Practice is not considered would be a legal quagmire I think for ignorance of the actual evidence.
Noting there is a low priority for Bactisure™ Wound Lavage and XPERIENCE here while the big money markets are prioritizes.
IF we had actual data on the Surgerys that surgeon had preformed and the number of post Surgical infections, the cost to the patients and the cost to the Hospital/ Health insurance funds - I suspect it would be fairly easy to ask the surgeon to consider those two preventative products or do as I would and find a smarter surgeon.
- Forums
- ASX - By Stock
- NXS
- Ann: Next Science US Medicare accreditation signals growth
Ann: Next Science US Medicare accreditation signals growth, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
-0.013(5.88%) |
Mkt cap ! $58.43M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $54.85K | 269.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67369 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67369 | 0.200 |
3 | 8700 | 0.195 |
1 | 54000 | 0.185 |
2 | 50000 | 0.180 |
1 | 5714 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 10000 | 1 |
0.225 | 4944 | 2 |
0.240 | 272 | 1 |
0.250 | 6000 | 2 |
0.255 | 75000 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online